Cargando…

The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia

Hematological and clinical chemistry measurements are an integral part of vaccine safety monitoring. While adopting a conservative approach is important to exclude potential risks for patients, the rationale and methodology underlying the assessment of given adverse events have to be well grounded t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vella, Venanzio, Schmidt, Johannes E., Cilio, Giulia Luna, De Ryck, Iris, Podda, Audino, Conti, Valentino, Auerbach, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684336/ https://www.ncbi.nlm.nih.gov/pubmed/34921644 http://dx.doi.org/10.1007/s40268-021-00370-3

Ejemplares similares

Correction: The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia
por: Vella, Venanzio, et al.
Publicado: (2022)

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia
por: De Ryck, Iris, et al.
Publicado: (2022)

Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia
por: De Ryck, Iris, et al.
Publicado: (2022)

Interpreting troponin elevations: do we need multiple diagnoses?
por: Pierpont, Gordon L., et al.
Publicado: (2009)

Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis
por: Silverberg, Jonathan I., et al.
Publicado: (2021)

Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain–Barré Syndrome and Narcolepsy
por: Stowe, Julia, et al.
Publicado: (2019)

Direct-to-consumer genetic testing: advantages and pitfalls
por: Oh, Bermseok
Publicado: (2019)

Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
por: Frenck, Robert W., et al.
Publicado: (2021)

A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development
por: Berlanda Scorza, Francesco, et al.
Publicado: (2022)

Pitfalls and Risks of “New Eating Disorders”: Let the Expert Speak!
por: Salatto, Alessia, et al.
Publicado: (2023)

On the pitfalls of peer review
por: van Gunsteren, Wilfred
Publicado: (2015)

The pitfalls of scaling up evidence-based interventions in health
por: Zomahoun, Hervé Tchala Vignon, et al.
Publicado: (2019)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Controversial role of plant sterol esters in the management of hypercholesterolaemia
por: Weingärtner, Oliver, et al.
Publicado: (2009)

Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human Pregnancy
por: Burton, G.J., et al.
Publicado: (2009)

Lipoprotein(a) as a cardiovascular risk factor: current status
por: Nordestgaard, Børge G., et al.
Publicado: (2010)

How does variability of immune system genes affect placentation?
por: Colucci, F., et al.
Publicado: (2011)

VARC consensus report: the FDA perspective(†)
por: Hillebrenner, Matthew G., et al.
Publicado: (2011)

Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses
por: Galiè, Nazzareno, et al.
Publicado: (2010)

Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis
por: Yousef, Zaheer, et al.
Publicado: (2013)

Potential Risks of Pharmacy Compounding
por: Gudeman, Jennifer, et al.
Publicado: (2013)

Extended Adjuvant Therapy with Imatinib in Patients with Gastrointestinal Stromal Tumors: Recommendations for Patient Selection, Risk Assessment, and Molecular Response Monitoring
por: Rutkowski, Piotr, et al.
Publicado: (2013)

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
por: Kowey, Peter R., et al.
Publicado: (2012)

Confusion: Acetaminophen Dosing Changes Based on NO Evidence in Adults
por: Krenzelok, Edward P., et al.
Publicado: (2012)

Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?
por: Atzor, Sabine, et al.
Publicado: (2013)

Managing Healthcare Budgets in Times of Austerity: The Role of Program Budgeting and Marginal Analysis
por: Mitton, Craig, et al.
Publicado: (2014)

Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?
por: Navarese, Eliano Pio, et al.
Publicado: (2013)

An Integrated Approach to Defining Genetic and Environmental Determinants for Major Clinical Outcomes Involving Vitamin D
por: Berlanga-Taylor, Antonio J., et al.
Publicado: (2014)

Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery
por: Sousa-Uva, Miguel, et al.
Publicado: (2014)

Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and Therapy
por: Trauner, Andrej, et al.
Publicado: (2014)

Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine()
por: Nevin, Remington L.
Publicado: (2014)

Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices
por: Smith, Meredith Y., et al.
Publicado: (2014)

Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest
por: Boyce, Richard D., et al.
Publicado: (2014)

Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?
por: Kanavos, Panos, et al.
Publicado: (2014)

Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications
por: Bello, Alfonso E., et al.
Publicado: (2014)

Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis
por: Scigliano, Giulio, et al.
Publicado: (2013)

Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
por: Edan, Gilles, et al.
Publicado: (2013)

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society
por: Nordestgaard, Børge G., et al.
Publicado: (2013)

Challenges in the Pharmacologic Management of Obesity and Secondary Dyslipidemia in Children and Adolescents
por: Kennedy, Mary Jayne, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6huj9g4agsj38ei3g9fgo0v8rn